Pfizer CEO Contracts COVID-19 Infection For Second Time

  • Pfizer Inc's PFE CEO Albert Bourla said he had tested positive for COVID-19.
  • "I'm feeling well and symptom-free," 60-year-old Bourla said in a statement. In August, he contacted COVID and received one course of paxlovid, Pfizer's oral COVID-19 antiviral treatment.
  • Bourla has received four doses of the COVID vaccine developed by Pfizer and BioNTech SE BNTX.
  • Bourla said he has not yet taken the new bivalent booster.
  • Developed by Moderna Inc MRNA and Pfizer/BioNTech, the updated bivalent shots aim to tackle the BA.5 and BA.4 Omicron subvariants, which make up 84.8% and 1.8%, respectively, of all circulating variants in the U.S., based on latest data, Reuters reported.
  • "I've not had the new bivalent booster yet, as I was following CDC guidelines to wait three months since my previous COVID case, which was back in mid-August," Bourla added.
  • A federal health agency said that over 25 million doses of the so-called bivalent shots had been sent out this week, mainly from Pfizer/BioNTech vaccine, as production of the Moderna vaccine ramps up.
  • Price Action: PFE shares are down 0.66% at $43.79 during the premarket session on the last check Monday.
Market News and Data brought to you by Benzinga APIs
Posted In: BiotechLarge CapNewsHealth CareMediaGeneralBriefsCOVID-19 CoronavirusCOVID-19 Vaccine
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!